CollPlant Biotechnologies Ltd (NAS:CLGN)
$ 6.15 -0.04 (-0.65%) Market Cap: 70.44 Mil Enterprise Value: 47.39 Mil PE Ratio: 0 PB Ratio: 2.48 GF Score: 46/100

Q4 2023 Collplant Biotechnologies Ltd Earnings Call Transcript

Apr 04, 2024 / 02:00PM GMT
Release Date Price: $5.26 (-3.57%)
Operator

Greetings, and welcome to the CollPlant Biotechnologies' investor conference call to discuss financial results for the full year and fourth quarter of 2023 and corporate updates. (Operator Instructions) As a reminder, this conference is being recorded.

Now I'll turn the call over to Dory Kurowski of LifeSci Advisors. Please go ahead.

Dory Kurowski
LifeSci Advisors, LLC - IR

I would like to welcome everyone to CollPlant Biotechnologies' financial results conference call to discuss the results for the full year and fourth quarter ended December 31, 2023, and provide a corporate business update.

With us on the call today from CollPlant are Yehiel Tal, Chief Executive Officer, who will provide an overview of the company's programs and associated updates; and Eran Rotem, Deputy CEO and Chief Financial Officer, who will provide a summary of CollPlant's financial results for the full year and fourth quarter ending December 31, 2023. Both will be available to answer questions at the end of the call.

Before we get started, I would like to

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot